Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	97656
Country	China

Received	2024-06-04 14:40
Peer-Review Started	2024-06-04 14:40
To Make the First Decision
Return for Revision	2024-08-11 01:40
Revised	2024-08-24 16:07
Second Decision	2024-09-27 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-27 08:32
Articles in Press	2024-09-27 08:32
Publication Fee Transferred	2024-10-03 09:34
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-10 07:54
Publish the Manuscript Online	2024-10-25 10:27

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Scientometrics
Article Title	Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective
Manuscript Source	Unsolicited Manuscript
All Author List	Xu Feng, Yi-Han Chai, Ke-Xin Jiang, Wen-Bin Jiang, Wen-Chao Chen and Yu Pan
ORCID	Author(s) ORCID Number Xu Feng http://orcid.org/0000-0002-4445-8174 Yi-Han Chai http://orcid.org/0000-0001-6392-6001 Wen-Bin Jiang http://orcid.org/0000-0002-4588-9670 Yu Pan http://orcid.org/0000-0003-2810-842X
Funding Agency and Grant Number	Funding Agency Grant Number the Zhejiang Provincial Medical and Health Science and Technology Program 2024KY1109
Corresponding Author	Yu Pan, MD, Physiotherapist, Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Qingchun East Road, Shangcheng District, Hangzhou 310016, Zhejiang Province, China. panyu1013@zju.edu.cn
Key Words	Olaparib; Pancreatic cancer; Bibliometric analysis; Breast cancer susceptibility gene; Poly (adenosine diphosphate–ribose) polymerase
Core Tip	Breast cancer gene (BRCA)1 and BRCA2 mutations affect 4%–7% of pancreatic cancer patients and influence their response to therapies such as platinum chemotherapy and poly (ADP-ribose) polymerase (PARP) inhibitors such as olaparib. A bibliometric analysis of 196 publications highlights growing global research interest, with China and the United States leading. The key contributors include O'Reilly EM's team and Memorial Sloan-Kettering, whereas the Journal of Clinical Oncology stands out for citations. Future trends point toward increased use of PARP inhibitors and combination therapies, offering valuable insights for advancing olaparib research in pancreatic cancer.
Publish Date	2024-10-25 10:27
Citation	<p>Feng X, Chai YH, Jiang KX, Jiang WB, Chen WC, Pan Y. Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective. <i>World J Gastrointest Oncol</i> 2024; 16(11): 4489-4505</p>
URL	https://www.wjgnet.com/1948-5204/full/v16/i11/4489.htm
DOI	https://dx.doi.org/10.4251/wjgo.v16.i11.4489

Full Article (PDF)	WJGO-16-4489-with-cover.pdf
PRISMA 2009 Checklist	97656-PRISMA-2009-Checklist.pdf
Manuscript File	97656_Auto_Edited_095540.docx
Answering Reviewers	97656-answering-reviewers.pdf
Audio Core Tip	97656-audio.m4a
Biostatistics Review Certificate	97656-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form	97656-conflict-of-interest-statement.pdf
Copyright License Agreement	97656-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	97656-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	97656-non-native-speakers.pdf
Peer-review Report	97656-peer-reviews.pdf
Scientific Misconduct Check	97656-scientific-misconduct-check.png
Scientific Editor Work List	97656-scientific-editor-work-list.pdf
CrossCheck Report	97656-crosscheck-report.png
CrossCheck Report	97656-crosscheck-report.pdf